Pictet Asset Management (Switzerland)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,199	Closed	-$6.82M	–	2037
2022 Q3	$6.82M	Buy	100,199 +8,033	+9%	+$443K	0.01%	661
2022 Q2	$2.94M	Buy	92,166 +41,568	+82%	+$1.22M	﹤0.01%	877
2022 Q1	$1.75M	Hold	50,598	–	–	﹤0.01%	984
2021 Q4	$1.48M	Buy	+50,598	New	+$1.57M	﹤0.01%	1029

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s GBT Position: Q4 2022 in Review

Pictet Asset Management (Switzerland) sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 100,199 shares — an estimated $6.82M sold.

Pictet Asset Management (Switzerland) first reported a position in GBT in Q4 2021 and held it in 4 quarters. The position peaked at $6.82M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Pictet Asset Management (Switzerland) reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 100,199 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $6.82M.
Pictet Asset Management (Switzerland) first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 4 quarters.
Pictet Asset Management (Switzerland)'s Global Blood Therapeutics, Inc. position peaked at $6.82M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 13 Feb 2023.